期刊文献+

重组犬α干扰素的制备及生物学活性分析 被引量:3

Preparation of recombinant canine interferon α and a comparative study of its biological activity
原文传递
导出
摘要 目的用毕赤酵母表达犬α干扰素并与诱生的犬天然白细胞干扰素作生物学活性比较。方法优化合成犬α干扰素基因,构建质粒pPIC9K-CaIFN-α,转入酵母SMD1168,筛选阳性克隆后诱导表达干扰素并纯化;并用犬白细胞诱生犬天然白细胞干扰素。用WISH-VSV方法检测两种干扰素的效价。结果表达的重组犬α干扰素效价约为0.65×105IU/ml,与犬白细胞干扰素效价(0.81×105 IU/ml)相近。结论成功利用毕赤酵母表达了与犬天然白细胞干扰素活性相近的重组犬α干扰素,为干扰素的工业化制备提供了种质资源。 Objective To develop recombinant canine alpha-interferon with Pichia pastoris. Methods A canine alpha interferon gene was optimized and synthesized. The plasmid pPICgK-CaIFN-α was constructed, and then the plasmid pPIC9K-CalFN-α was transformed into P. pastoris SMDl168. Positive clones were selected, interferon protein was in duced and purified, and canine spontaneous leukocyte interferon was produced by stimulation with the Newcastle disease virus (NDV). The titer of two forms of interferon was determined with a WISH-VSV system. Results The antiviral activity of recombinant canine alpha-interferon (0.65 ×10^5IU/ml) was similar to that of canine spontaneous leukocyte in- terferon (0.81 ×10^5IU/ml). Conclusion Recombinant canine alpha-interferon, whose antiviral activity resembles that of canine spontaneous leukocyte interferon, was successfully expressed by P. pastoris. This study lays the foundation for the industrial production of interferon.
出处 《中国病原生物学杂志》 CSCD 北大核心 2013年第4期307-309,共3页 Journal of Pathogen Biology
基金 国家科技支撑计划项目(No.2013BAD12B04)
关键词 重组犬α干扰素 毕赤酵母 白细胞干扰素 Recombinant canine alpha-interferon Pichia pastoris leukocyte interferon
  • 相关文献

参考文献7

  • 1侯云德.干扰素及其临床应用 一 干扰素概述、定义和分类[J].中华实验和临床病毒学杂志,2007,21(4):408-411. 被引量:13
  • 2Kauffman M A, Sterin Prync A, Papouchado M, et al. Immuno genicity of an interferon-beta la product[J]. Int J Immunopathol Pharmacol, 2011, 24(2): 499-504.
  • 3Familletti PC, Rubinstein S, Pestka S. A convenient and rapid cytopathic effect inhibition assay for interferon[J]. Meth Enzy mol, 1981, 78: 387 94.
  • 4Ruttanapumma R, Anzai M, Takegawa M, et al. High level ex pression of biologically active canine interferon-alpha subtype 4 u- sing a baculovirus[J]. J Vet Med Sci, 2006, 68(12) : 1347 9.
  • 5Lawrence LW, Park MS, Martinez O, et al. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacy- told dendritic eells[J]. Immunol Cell Biol, 2011, 89 (7) : 792 - 8O2.
  • 6Rieder M, Brzozka K, Pfaller CK, et al. Genetic dissection of in- terferon-antagonistic functions of rabies virus phosphoprotein: in hibition of interferon regulatory factor 3 activation is important for pathogenicity[J]. J Virol, 2011, 85(2): 842-52.
  • 7Malinoski CP, Marcus L. Influenza virus= a single noninfectious interferon induction-suppressing particle blocks expression of in- terferon inducing particles[J]. J Interf Cytokine Res, 2012, 32 (3) = 121-6.

二级参考文献6

  • 1Cantell K. The Story of Interferon, 1997.
  • 2DANIEL JJ. CARR: Interferon Methods And Protocols. Humana Pr lnc, 2005.
  • 3Isaacs A, Lindenmann J. Virus Interference. I. The interferon. Proc Roy Soc Lond B Biol Sci, 1957, 147:258-267.
  • 4Nagano Y, Kojima Y. "Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets" CR Seanees Soc Biol Fil, 1954, 148: 1700-1702.
  • 5Nagano Y, Kojima Y. " Inhibition de l'infection vaccinale par un facteur liquide dans le tissu infecte par le virus homologue". CR Seances Soc Biol Fil, 1958, 152:1627-1629.
  • 6Vilcek, Novel interferons. Nature Immunology, 2003, 4:8-9.

共引文献12

同被引文献17

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部